Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations

Virology

Volumn 230, Issue 1, 1997, Pages 134-144

  Bess Jr , Julian W ^a   Gorelick, Robert J ^a   Bosche, William J ^a   Henderson, Louis E ^a   Arthur, Larry O ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; VIRUS GLYCOPROTEIN;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS ISOLATION; VIRUS PARTICLE; VIRUS PURIFICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031592573     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8499     Document Type: Article

References (46)

1. Arthur L. O., Bess J. W. Jr., Sowder R. C. III, Benveniste R. E., Mann D. L., Chermann J.-C., Henderson L. E. Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines. Science. 258:1992;1935-1938.
2. Arthur L. O., Bess J. W. Jr., Urban R. G., Strominger J. L., Morton W. R., Mann D. L., Henderson L. E., Benveniste R. E. Macaques immunized with HLA DR are protected from SIV challenge. J. Virol. 69:1995;3117-3124.
3. Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. Current Protocols in Molecular Biology. 1995;Wiley, New York. p. A3.9-A3.10.
4. Bess J. W. Jr., Powell P. J., Issaq H. J., Schumack L. J., Grimes M. K., Henderson L. E., Arthur L. O. Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type I, and other retroviruses. J. Virol. 66:1992;840-847.
5. Blanton M., Balakrishnan K., Dumaswala U., Zelenski K., Greenwalt T. J. HLA antibodies in blood donors with reactive screening tests for antibody to the immunodeficiency virus. Transfusion. 27:1987;118-119.
6. CPZ. J. Virol. 70:1996;4220-4227.
7. MAC-23H. AIDS. 9:1995;223-228.
8. Castilletti C., Capobianchi M. R., Abbate I., Ficociello B., Amegilo F., Cordiali Fei P., Santini S. M., Dianzani F. HIV type 1 grown in interferon γ-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA DR and enhanced infectivity for CD4-negative cells. AIDS Res. Hum. Retroviruses. 11:1995;547-553.
9. L. G. Davis, M. D. Dibner, J. F. Battery, 1986, Basic Methods in Molecular Biology, 130, 138, Elsevier, New York.
10. Drabick J. J., Baker J. R. HLA antigen contamination of commercial western blot strips for detecting human immunodeficiency virus. J. Infect. Dis. 159:1989;357-358.
11. Franke E. K., Yuan E. H., Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature (London). 372:1994;359-362.
12. Gehle W. D., Smith K. O. Enumeration of virus particles in ultrathin sectioned pellets. Proc. Soc. Exptl. Biol. Med. 135:1970;490-494.
13. Gelderbloom H., Reupke H., Winkel T., Kunze R., Pauli G. MHC-antigens: constituents of the envelopes of human and simian immunodeficiency viruses. Zeitschrift fur Naturforschung (C). 42:1987;1328-1334.
14. Gluschankof P., Mondor I., Gelderblom H. R., Sattentau Q. J. Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations. Virology. 230:1997;125-133.
15. Gorelick R. J., Nigida S. M. Jr., Bess J. W. Jr., Arthur L. O., Henderson L. E., Rein A. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J. Virol. 46:1990;3207-3211.
16. Henderson L. E., Sowder R. S., Copeland T. D., Oroszlan S. O., Arthur L. O., Robey W. G., Fischinger P. J. Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III. J. Virol. 61:1987;629-632.
17. Hoxie J. A., Fitzharris T. P., Youngbar P. R., Matthews D. M., Rackowski J. L., Radka S. F. Nonrandom association of cellular antigens with HTLV-III virions. Human Immun. 18:1987;39-52.
18. Hunter J. B., Menitove J. E. HLA antibodies detected by ELISA HTLV-III antibody kits. Lancet. II:1985;397.
19. Kannagi M., Kiyotaki M., King N. W., Lord C. I., Letvin N. L. Simian Immunodeficiency virus induces expression of class II major histocompatibility complex structures on infected target cells in vitro. J. Virol. 61:1987;1421-1426.
20. Kerkau T., Schmitt-Landgraf R., Schimpl A., Wecker E. Downregulation of HLA class I antigens in HIV-1-infected cells. AIDS Res. Hum. Retroviruses. 5:1989;613-620.
21. Kühnl P., Seidl S., Holzberger G. HLA DR4 antibodies cause false positive HTLV-III antibody ELISA results. Lancet. I:1985;1222-1223.
22. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
23. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
24. Luban J., Bossolt K. L., Franke E. K., Kalpana G. V., Goff S. P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell. 73:1993;1067-1078.
25. Mann D. L., Read-Connole E., Arthur L. O., Robey W. G., Wernet P., Schneider E. M., Blattner W. A., Popovic M. HLA DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens. J. Immunol. 141:1988;1131-1136.
26. Mann D. L., O'Brien S. J., Gilbert D. A., Reid Y., Popovic M., Read-Connole E., Gallo R. C., Gazdar A. F. Origin of the HIV-susceptible human CD4+ cell line H9. AIDS Res. Hum. Retroviruses. 5:1989;253-255.
27. Meerloo T., Sheikh M. A., Bloem A. C., de Ronde A., Schutten M., van Els C. A. C., Roholl P. M. J., Joling P., Goudsmit J., Schuurman H.-J. Host cell membrane proteins on human immunodeficiency virus type 1 afterin vitro. J. Gen. Virol. 74:1993;129-135.
28. Minowada J., Ohnuma T., Moore G. E. Rosette-forming human lymphoid cell lines. 1. Establishment and evidence for origin of thymus-derived lymphocytes. J. Natl. Cancer Inst. 49:1972;891-895.
29. Nara P. L., Hatch W. C., Dunlop N. M., Robey W. G., Arthur L. O., Gonda M. A., Fischinger P. F. Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res. Hum. Retroviruses. 3:1987;283-302.
30. Noraz N., Verrier B., Fraisier C., Desgranges C. Cell surface changes induced in H9 T cells chronically infected with HTLV type I or HIV type 1 or coinfected with the two viruses. AIDS Res. Hum. Retroviruses. 11:1995;145-154.
31. Orentas R. J., Hildreth J. E. K. Association of host cell surface adhesion receptors and other membrane proteins with SIV and HIV. AIDS Res. Hum. Retroviruses. 9:1993;1157-1165.
32. Ott D. E., Nigida S. M., Henderson L. E., Arthur L. O. The majority of cells are superinfected in a cloned cell line that produces high levels of human immunodeficiency type 1 strain MN. J. Virol. 69:1995a;2443-2450.
33. Ott D. E., Coren L. V., Johnson D. J., Sowder R. C. III, Arthur L. O., Henderson L. E. Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain. AIDS Res. Hum. Retroviruses. 11:1995b;1003-1006.
34. Ott D. E., Coren L. V., Kane B. P., Busch L. K., Johnson D. J., Sowder R. C. II, Chertova E. N., Arthur L. O., Henderson L. E. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J. Virol. 70:1996;7734-7743.
35. Owens R. J., Dubay J. W., Hunter E., Compans R. W. Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells. Proc. Natl. Acad. Sci. USA. 88:1991;3987-3991.
36. Popovic M., Sarngadharan M. G., Read E., Gallo R. C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science. 224:1984;497-500.
37. Raposo G., Nijman H. W., Stoorvogel W., Leijendekker R., Harding C. V., Melief C. J. M., Geuze H. J. B Lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183:1996;1161-1172.
38. Reitz M. S. Jr., Guo H.-G., Oleske J., Hoxie J., Popovic M., Read-Connole E., Markham P., Streicher H., Gallo R. C. On the historical origins of HIV-1(MN) and RF. AIDS Res. Hum. Retroviruses. 8:1992;1539-1541.
39. Rossio J. L., Bess J. W. Jr., Henderson L. E., Cresswell P., Arthur L. O. HLA class II on HIV-1 particles is functional in superantigen presentation to human T cells: Implications for HIV pathogenesis. AIDS Res. Hum. Retroviruses. 11:1995;1433-1439.
40. Sayers M. H., Beatty P. G., Hansen J. A. HLA antibodies as a cause of false-positive reactions in screening enzyme immunoassays for antibodies to human T-lymphotropic virus type III. Transfusion. 26:1986;113-115.
41. Schols D., Pauwels R., Desmyter J., DeClerq E. Presence of class II histocompatibility DR proteins on the envelope of human immunodeficiency virus demonstrated by FACS analysis. Virology. 189:1992;74-376.
42. Stevenson M., Zhang X., Volsky D. J. Downregulation of cell surface molecules during noncytopathic infection of T cells with human immunodeficiency virus. J. Virol. 61:1987;3741-3748.
43. Stott E. J. Anti-cell antibody in macaques. Nature. 353:1991;393.
44. Thali M., Bukovsky E., Kondo B., Resenwirth B., Walsh C. T., Sodroski J., Gottlinger H. G. Functional association of cyclophilin A with HIV-1 virions. Nature (London). 372:1994;363-365.
45. Wrightham M., Schimpf A., Pennington T. H., Walker F., Sewell H. F. HIV induces modulation of functionally important cellular antigens. Clin. Exp. Immunol. 85:1991;75-79.
46. Yu X., Yuan X., Masuda Z., Lee T.-H., Essex M. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J. Virol. 66:1992;4966-4971.